pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 13·1 min read
save

Health secretary Kennedy pushes new addiction-treatment strategy in California, criticizes prior administration

Aug 13, 2026·read at STAT ↗RegulatoryNeutral

Health secretary Robert F. Kennedy Jr. traveled to California to present the Biden administration’s revised plan for addiction treatment, following a recent White House initiative on vaccine policy.

During the visit, Kennedy blamed the previous administration, specifically former California health chief Dr. Becerra, for past shortcomings in addressing addiction.

The trip underscores a broader federal effort to reshape how addiction services are delivered, which could affect funding, regulatory pathways, and market opportunities for companies developing treatment drugs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Kennedy heads west, slams Becerra”

read at STAT ↗
452 words · retrieved Aug 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
insulin
topics
Vaccines3Vaccine2

related stories

  • Aug 26Inside the Gulf biotech deal model, ahead of RGMBS 2026 in RiyadhBioSpace
  • Aug 17STAT+: Kennedy’s split-screen week: Talk of vaccines in D.C., fraud and addiction out WestSTAT
  • Aug 13STAT+: Newsom promotes affordable insulin, but California’s generic label is off to a slow startSTAT
  • Apr 25Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugsSTAT
  • May 6STAT+: Even at a meeting in Rome, FDA shifts are top of mind for gene therapy fieldSTAT